Filing Flows › Assembly Biosciences (ASMB) › Q1 2026 › vs Q1 2025
Assembly Biosciences (ASMB) Q1 2026 vs Q1 2025 (year over year)
Assembly Biosciences's revenue fell $1.2M (-13%) from $9.4M in Q1 2025 to $8.2M in Q1 2026.
Assembly Biosciences, Q1 2026: revenue $8.2M (-13% year over year), operating margin -138.4%, net loss $9.1M, operating cash flow −$22.1M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $8.2M | $9.4M | −$1.2M | -13% |
| Other income, net | $2.3M | $1.1M | $1.2M | +104% |
| Net loss | $9.1M | $8.8M | $261K | +3% |
| Costs & expenses | $19.6M | $19.4M | $223K | +1% |
| Operating costs | $19.6M | $19.4M | $223K | +1% |
| Research & development | $14.9M | $14.9M | $49K | +0.3% |
| General & admin | $4.7M | $4.5M | $174K | +4% |
| Operating cash sources | $23.2M | $24.2M | −$945K | -4% |
| Depreciation & amortization | $26K | $33K | −$7K | -21% |
| Share-based compensation | $1.1M | $712K | $404K | +57% |
| Cash used in operations | $22.1M | $23.4M | −$1.3M | -6% |
| Net loss absorbed | $9.1M | $8.8M | $261K | +3% |
| Working capital & other | $14.2M | $15.4M | −$1.2M | -8% |
Questions
How much did Assembly Biosciences's revenue grow year over year in Q1 2026?
Assembly Biosciences's revenue fell $1.2M (-13%) from $9.4M in Q1 2025 to $8.2M in Q1 2026.